HOLLY JULIAN: Open Payments
NPI 1902553407 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,670 in 135 payments from 14 companies in 2025. Trend: 2023 $159 · 2024 $3,196 · 2025 $2,670
Food & beverage: $2,662Education: $8
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 25 | $400 |
| Otsuka America Pharmaceutical, Inc. | 18 | $395 |
| Alkermes, Inc. | 16 | $276 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $240 |
| E.R. Squibb & Sons, L.L.C. | 13 | $236 |
| Janssen Pharmaceuticals, Inc | 8 | $223 |
| Vanda Pharmaceuticals Inc. | 7 | $213 |
| Neurocrine BioSciences, Inc. | 6 | $168 |
| Teva Pharmaceuticals USA, Inc. | 11 | $148 |
| Axsome Therapeutics, Inc. | 7 | $143 |
Products named: Qelbree, REXULTI, ARISTADA, CAPLYTA, COBENFY, INGREZZA, HETLIOZ, Auvelity.
Industry payments across MO — which companies pay providers there.
